NCT06990061View on ClinicalTrials.gov

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 1, 2028

Study Completion Date

September 18, 2031

Conditions
Non-Muscle Invasive Bladder Cancer
Interventions
RADIATION

Radiation therapy

Radiation therapy will be given in 20 fractions of 2.75 Gy (total dose of 55 Gy) covering the whole bladder over 4 weeks in combination.

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK